KEY
46
-7
AMG
30
-3
REGN
62
-2
WFC
49
-11
CMS
65
-2
COF
49
-6
UNP
56
-4
TJX
51
-3
PFE
23
-2
JCI
44
-3
ORLY
60
-5
INTC
22
-2
NWSA
54
-4
RRC
39
-3
MNST
54
2
ORCL
59
-3
MCHP
32
-6
WMB
55
-4
NOC
56
2
SE
55
-3
KEY
46
-7
AMG
30
-3
REGN
62
-2
WFC
49
-11
CMS
65
-2
COF
49
-6
UNP
56
-4
TJX
51
-3
PFE
23
-2
JCI
44
-3
ORLY
60
-5
INTC
22
-2
NWSA
54
-4
RRC
39
-3
MNST
54
2
ORCL
59
-3
MCHP
32
-6
WMB
55
-4
NOC
56
2
SE
55
-3
Financhill
Back

CRISPR Therapeutics AG Vs. Editas Medicine Industry Stock Comparison

Sell
30

CRSP
CRISPR Therapeutics AG

Last Price:
44.58
Seasonality Move:
6.48%
Sell
29

EDIT
Editas Medicine

Last Price:
3.60
Seasonality Move:
-2.38%
Sell
30
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $44.62. The Score for CRSP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.60. The Score for EDIT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $44.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight buying pressure.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.9 Sell
Relative Strength Index (14 RSI): 35.02 Sell
Chaikin Money Flow: 106871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.24 - 49.44) Sell
Bollinger Bands (100): (49.81 - 58.91) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 36.25 Sell
Chaikin Money Flow: 1542488 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.59 - 4.33) Sell
Bollinger Bands (100): (4.31 - 5.71) Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.43 Sell
20-day SMA: 47.55 Sell
50-day SMA: 52.01 Sell
200-day SMA: 61.76 Sell
8-day EMA: 46.16 Sell
20-day EMA: 47.9 Sell
50-day EMA: 51.21 Sell
200-day EMA: 57.09 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.63 Sell
20-day SMA: 3.82 Sell
50-day SMA: 4.58 Sell
200-day SMA: 6.89 Sell
8-day EMA: 3.64 Sell
20-day EMA: 3.9 Sell
50-day EMA: 4.45 Sell
200-day EMA: 6.25 Sell

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.00 per share, a decrease this year of $2.74 per share, and an increase next year of $0.45 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.68 per share, and an increase next year of $0.17 per share.

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):